Karen Elizabeth Hoffman, M.D., M.H.Sc., M.P.H.

Peer-Reviewed Articles

1. Laviana AA, Hernandez A, Huang LC, Zhao Z, Koyama T, Conwill R, Hoffman K , Feurer ID, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O'Neil BB, Kaplan SH, Greenfield S, Penson DF, Barocas DA. Interpretation of Domain Scores on the EPIC-How Does the Domain Score Translate into Functional Outcomes?. J Urol 202(6):1150-1158, 2019. e-Pub 2019. PMID: 31216252.
2. E.A. Strom, P.K. Allen, T. Williamson, F. Poenisch, R.A. Amos, W.A. Woodward, M.C. Stauder, S.F. Shaitelman, B.D. Smith, G.H. Perkins, W. Tereffe, K.E. Hoffman . Prospectively Assessed Outcomes for Proton Accelerated Partial Breast Irradiation. International Journal of Radiation Oncology Biology Physics 105(1):S193, 2019. e-Pub 2019.
3. Christopherson K, Lei X, Barcenas C, Buchholz TA, Garg N, Hoffman KE, Kuerer HM, Mittendorf E, Perkins G, Shaitelman SF, Smith GL, Stauder M, Strom EA, Tereffe W, Woodward WA, Smith BD. Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement. Int J Radiat Oncol Biol Phys 104(3):574-581, 2019. e-Pub 2019. PMID: 30851348.
4. Pasalic D, Kuban DA, Allen PK, Tang C, Mesko SM, Grant SR, Augustyn AA, Frank SJ, Choi S, Hoffman KE , Nguyen QN, McGuire SE, Pollack A, Anscher MS. Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase 3, Single Institution Randomized Clinical Trial. International Journal of Radiation Oncology Biology Physics 104(4):790-797, 2019. e-Pub 2019. PMID: 30836166.
5. Singh P, Hoffman K , Schaverien MV, Krause KJ, Butler C, Smith BD, Kuerer HM. Neoadjuvant Radiotherapy to Facilitate Immediate Breast Reconstruction: A Systematic Review and Current Clinical Trials. Ann Surg Oncol 26(10):3312–3320. e-Pub 2019. PMID: 31342362.
6. Lairson DR, Wu CF, Chan W, Fu S, Hoffman KE, Pettaway CA. Mean treatment cost of incident cases of penile cancer for privately insured patients in the United States. Urol Oncol 37(4):294.e17-294.e25, 2019. e-Pub 2019. PMID: 30660492.
7. Logan JK, Jiang J, Shih YT, Lei X, Xu Y, Hoffman KE , Giordano SH, Smith BD. Trends in Radiation for Bone Metastasis During a Period of Multiple National Quality Improvement Initiatives. J Oncol Pract 15(4):e356-e368, 2019. e-Pub 2019. PMID: 30849005.
8. Reichard CA, Hoffman KE , Tang C, Williams SB, Allen PK, Achim MF, Kuban DA, Chapin BF. Radical prostatectomy or radiotherapy for high- and very high-risk prostate cancer: a multidisciplinary prostate cancer clinic experience of patients eligible for either treatment. BJU Int. e-Pub 2019. PMID: 31009137.
9. Morgan SC, Hoffman K , Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, Ray M, Sandler H. Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based Guideline. J Urol 201(3):528-534, 2019. PMID: 30759696.
10. Stecklein SR, Shaitelman SF, Babiera GV, Bedrosian I, Black DM, Ballo MT, Arzu I, Strom EA, Reed VK, Dvorak T, Smith BD, Woodward WA, Hoffman KE , Schlembach PJ, Kirsner SM, Nelson CL, Yang J, Guerra W, Dibaj S, Bloom ES. Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation with Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy. Pract Radiat Oncol 9(1):e4-e13, 2019. e-Pub 2018. PMID: 30125673.
11. Yang DD, Mahal BA, Muralidhar V, Martin NE, Orio PF, Mouw KW, King MT, Choueiri TK, Trinh QD, Hoffman KE , Spratt DE, Feng FY, Nguyen PL. Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer. Eur Urol 75(1):35-41, 2019. e-Pub 2018. PMID: 30554605.
12. Grossberg AJ, Lei X, Xu T, Shaitelman SF, Hoffman KE , Bloom ES, Stauder MC, Tereffe W, Schlembach PJ, Woodward WA, Buchholz TA, Smith BD. Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol 4(12):1751-1757, 2018. e-Pub 2018. PMID: 30027292.
13. Morgan SC, Hoffman K , Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, Ray M, Sandler H. Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline. Pract Radiat Oncol 8(6):354-360, 2018. e-Pub 2018. PMID: 30322661.
14. Hoffman KE , Voong KR, Levy LB, Allen PK, Choi S, Schlembach PJ, Lee AK, McGuire SE, Nguyen Q, Pugh TJ, Frank SJ, Kudchadker RJ, Du W, Kuban DA. Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer. J Clin Oncol 36(29):JCO2018779868, 2018. e-Pub 2018. PMID: 30106637.
15. Shaitelman SF, Lei X, Thompson A, Schlembach P, Bloom ES, Arzu IY, Buchholz D, Chronowski G, Dvorak T, Grade E, Hoffman K , Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Amaya DN, Shen Y, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BD. Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial. J Clin Oncol:JCO1800317. e-Pub 2018. PMID: 30379626.
16. Lee DJ, Barocas DA, Zhao Z, Huang LC, Resnick MJ, Koyoma T, Conwill R, McCollum D, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Penson DF, Hoffman KE . Comparison of Patient-Reported Outcomes After External Beam Radiation Therapy and Combined External Beam with Low-Dose Rate Brachytherapy Boost in Men with Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 102(1):116-126, 2018. e-Pub 2018. PMID: 30102188.
17. Ovalle V, Strom EA, Shaitelman S, Hoffman K , Amos R, Perkins G, Tereffe W, Smith BD, Stauder M, Woodward W. Proton Partial Breast Irradiation: Detailed Description of Acute Clinico-Radiologic Effects. Cancers (Basel) 10(4), 2018. e-Pub 2018. PMID: 29642467.
18. Hoffman KE . Contemporary Prostate Cancer Radiation Therapy in the United States: Patterns of Care and Compliance with Quality Measures. Practical Radiation Oncology 8(5):307-316, 2018. PMID: 30177030.
19. Dinh KT, Aizer AA, Muralidhar V, Mahal BA, Chen YW, Beard CJ, Choueiri TK, Hoffman KE , Hu JC, Martin NE, Sweeney CJ, Trinh QD, Nguyen PL. Increased Vulnerability to Poorer Cancer-Specific Outcomes Following Recent Divorce. Am J Med. e-Pub 2018. PMID: 29555248.
20. Pan HY, Jiang J, Hoffman KE , Tang C, Choi SL, Nguyen QN, Frank SJ, Anscher MS, Shih YT, Smith BD. Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer. J Clin Oncol:JCO2017755371. e-Pub 2018. PMID: 29561693.
21. Smith BD, Bellon JR, Blitzblau R, Freedman G, Haffty B, Hahn C, Halberg F, Hoffman K , Horst K, Moran J, Patton C, Perlmutter J, Warren L, Whelan T, Wright JL, Jagsi R. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol. e-Pub 2018. PMID: 29545124.
22. Tyson MD, Koyama T, Lee D, Hoffman KE , Resnick MJ, Wu XC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Paddock LE, Stroup A, Chen V, Conwill R, McCollum D, Penson DF, Barocas DA. Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results. Eur Urol. e-Pub 2018. PMID: 29501451.
23. Mahal BA, Chen YW, Sethi RV, Padilla OA, Yang DD, Chavez J, Muralidhar V, Hu JC, Feng FY, Hoffman KE , Martin NE, Spratt DE, Yu JB, Orio PF, Nguyen PL. Travel distance and stereotactic body radiotherapy for localized prostate cancer. Cancer. e-Pub 2017. PMID: 29231964.
24. Avulova S, Zhao Z, Lee D, Huang LC, Koyama T, Hoffman KE , Conwill RM, Wu XC, Chen V, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Paddock LE, Stroup A, Resnick MJ, Penson DF, Barocas DA. The Effect of Nerve Sparing Status on Sexual and Urinary Function: 3-Year Results from the CEASAR Study. J Urol. e-Pub 2017. PMID: 29253578.
25. Yang DD, Krasnova A, Nead KT, Choueiri TK, Hu JC, Hoffman KE , Yu JB, Spratt DE, Feng FY, Trinh QD, Nguyen PL. Androgen Deprivation Therapy and Risk of Rheumatoid Arthritis in Patients with Localized Prostate Cancer. Ann Oncol. e-Pub 2017. PMID: 29267861.
26. Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K , Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Sloane RS, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Sanchez EMR, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. e-Pub 2017. PMID: 29097493.
27. Woodward WA, Fang P, Arriaga L, Gao H, Cohen EN, Reuben JM, Valero V, Le-Petross H, Middleton LP, Babiera GV, Strom EA, Tereffe W, Hoffman K , Smith BD, Buchholz TA, Perkins GH. A Phase 2 Study of Preoperative Capecitabine and Concomitant Radiation in Women With Advanced Breast Cancer. Int J Radiat Oncol Biol Phys 99(4):777-783, 2017. e-Pub 2017. PMID: 28843370.
28. Ayoub Z, Strom EA, Ovalle V, Perkins GH, Woodward WA, Tereffe W, Smith BD, Shaitelman SF, Stauder MC, Hoffman KE , DeSnyder SM, Garvey PB, Clemens MW, Barcenas CH, Kuerer HM, Kronowitz S. A 10-Year Experience with Mastectomy and Tissue Expander Placement to Facilitate Subsequent Radiation and Reconstruction. Ann Surg Oncol 24(10):2965-2971, 2017. e-Pub 2017. PMID: 28766219.
29. Blanchard P, Davis JW, Frank SJ, Kim j, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman KE , Navai N, Achim M, McGuire SE, Matin SF, Nguyen Q, Mahmood U, Graber WJ, Chen HC, Wang X, Kuban DA. Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort. BJU International, 2017. e-Pub 2017. PMID: 28941030.
30. Weiss A, Mittendorf EA, DeSnyder SM, Hwang RF, Bea V, Bedrosian I, Hoffman K , Adrade B, Sahin AA, Kuerer HM, Hunt KK, Caudle AS. Expanding Implementation of ACOSOG Z0011 in Surgeon Practice. Clin Breast Cancer. e-Pub 2017. PMID: 29100726.
31. Frank SJ, Pugh TJ, Blanchard P, Mahmood U, Graber WJ, Kudchadker RJ, Davis JW, Kim J, Choi H, Troncoso P, Kuban DA, Choi S, McGuire S, Hoffman KE , Chen HC, Wang X, Swanson DA. Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes. Int J Radiat Oncol Biol Phys. e-Pub 2017. PMID: 29229325.
32. Williams SB, Huo J, Chapin BF, Smith BD, Hoffman KE . Impact of urologists' ownership of radiation equipment in the treatment of prostate cancer. Prostate Cancer Prostatic Dis 20(3):300-304, 2017. e-Pub 2017. PMID: 28349981.
33. Yang DD, Muralidhar V, Mahal BA, Nezolosky MD, Labe SA, Vastola ME, Boldbaatar N, King MT, Martin NE, Orio PF, Choueiri TK, Trinh QD, Den RB, Spratt DE, Hoffman KE , Feng FY, Nguyen PL. Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy. Urol Oncol 35(9):542.e25-542.e32, 2017. e-Pub 2017. PMID: 28533151.
34. Tyson MD, Alvarez J, Koyama T, Hoffman KE , Resnick MJ, Wu XC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Paddock LE, Stroup A, Chen VW, Penson DF, Barocas DA. Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study. Eur Urol 72(2):307-314, 2017. e-Pub 2016. PMID: 27816300.
35. Williams SB, Duan Z, Chamie K, Hoffman KE , Smith BD, Hu JC, Shah JB, Davis JW, Giordano SH. Risk of hospitalisation after primary treatment for prostate cancer. BJU Int 120(1):48-55, 2017. e-Pub 2016. PMID: 27561186.
36. Voong KR, Lal LS, Kuban DA, Pugh TJ, Swint JM, Godby J, Choi S, Lee AK, Schlembach PJ, Frank SJ, McGuire SE, Hoffman KE . Long-term economic value of hypofractionated prostate radiation: Secondary analysis of a randomized trial. Adv Radiat Oncol 2(3):249-258, 2017. e-Pub 2017. PMID: 29114589.
37. Fang P, He W, Gomez DR, Hoffman KE , Smith BD, Giordano SH, Jagsi R, Smith GL. Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States. Int J Radiat Oncol Biol Phys 98(4):748-757, 2017. e-Pub 2017. PMID: 28366580.
38. Basourakos SP, Hoffman K , Kim J. Active surveillance in prostate cancer: new efforts, new voices, new hope. BJU Int 120(1):4-5, 2017. PMID: 28621062.
39. Yang DD, Muralidhar V, Mahal BA, Labe SA, Nezolosky MD, Vastola ME, King MT, Martin NE, Orio PF, Choueiri TK, Trinh QD, Spratt DE, Hoffman KE , Feng FY, Nguyen PL. National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 98(2):338-343, 2017. e-Pub 2017. PMID: 28463152.
40. Yang DD, Mahal BA, Muralidhar V, Nezolosky MD, Vastola ME, Labe SA, Boldbaatar N, King MT, Martin NE, Orio PF, Beard CJ, Hoffman KE , Trinh QD, Spratt DE, Feng FY, Nguyen PL. Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate Cancer. Eur Urol Focus. e-Pub 2017. PMID: 28753811.
41. Williams SB, Huo J, Chamie K, Smaldone MC, Kosarek CD, Fang JE, Ynalvez LA, Kim SP, Hoffman KE , Giordano SH, Chapin BF. Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: The limitations of cancer registry data. Cancer 123(9):1617-1624, 2017. e-Pub 2017. PMID: 28099688.
42. Lang MF, Tyson MD, Alvarez JR, Koyama T, Hoffman KE , Resnick MJ, Cooperberg MR, Wu XC, Chen V, Paddock LE, Hamilton AS, Hashibe M, Goodman M, Greenfield S, Kaplan SH, Stroup A, Penson DF, Barocas DA. The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-based Cohort. Urology 103:173-178, 2017. e-Pub 2017. PMID: 28189554.
43. Mahal BA, Chen YW, Muralidhar V, Mahal AR, Choueiri TK, Hoffman KE , Hu JC, Sweeney CJ, Yu JB, Feng FY, Kim SP, Beard CJ, Martin NE, Trinh QD, Nguyen PL. Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States. Ann Oncol 28(5):1098-1104, 2017. PMID: 28453693.
44. Holliday EB, Kuban DA, Levy LB, Bolukbasi Y, Master P, Choi S, Nguyen Q, McGuire SE, Mahmood U, Frank SJ, Hoffman KE. Select men benefit from androgen deprivation therapy delivered with salvage radiation therapy after prostatectomy. Prostate Cancer Prostatic Dis. e-Pub 2017. PMID: 28462945.
45. Reddy JP, Pettaway CA, Levy LB, Pagliaro LC, Tamboli P, Rao P, Jayaratna I, Hoffman KE . Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma. BJU Int 119(4):591-597, 2017. e-Pub 2016. PMID: 27753187.
46. Eifler JB, Alvarez J, Koyama T, Conwill RM, Ritch CR, Hoffman KE , Resnick MJ, Penson DF, Barocas DA, Collaborators. More judicious use of expectant management for localized prostate cancer over the past two decades. J Urol 197(3 Pt 1):614-620, 2017. e-Pub 2016. PMID: 27984110.
47. Moran MS, Zhao Y, Ma S, Kirova Y, Fourquet A, Chen P, Hoffman KE , Hunt K, Wong J, Halasz LM, Freedman G, Prosnitz R Jr, Yassa M, Nguyen DH, Hijal T, Haffty BG, Wai ES, Truong PT. Association of Radiotherapy Boost for Ductal Carcinoma In Situ With Local Control After Whole-Breast Radiotherapy. Journal of American Medical Association Oncology, 2017. e-Pub 2017. PMID: 28358936.
48. Barocas DA, Alvarez J, Resnick MJ, Koyama T, Hoffman KE , Tyson MD, Conwill R, McCollum D, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Penson DF. Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years. JAMA 317(11):1126-1140, 2017. PMID: 28324093.
49. Chen YW, Muralidhar V, Mahal BA, Nezolosky MD, Beard CJ, Choueiri TK, Hoffman KE , Martin NE, Orio PF, Sweeney CJ, Feng FY, Trinh QD, Nguyen PL. Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancer. Brachytherapy 15(6):695-700, 2016. e-Pub 2016. PMID: 27528590.
50. Stauder MC, Caudle AS, Allen PK, Shaitelman SF, Smith BD, Hoffman KE , Buchholz TA, Chavez-Macgregor M, Hunt KK, Meric-Bernstam F, Woodward WA. Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy. Int J Radiat Oncol Biol Phys 96(3):637-44, 2016. e-Pub 2016. PMID: 27681760.
51. Mahal BA, Chen YW, Muralidhar V, Mahal AR, Choueiri TK, Hoffman KE , Hu JC, Sweeney CJ, Yu JB, Feng FY, Kim SP, Beard CJ, Martin NE, Trinh QD, Nguyen PL. National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers?. Cancer 122(21):3371-3377, 2016. e-Pub 2016. PMID: 27434225.
52. Hoffman KE, Skinner H, Pugh TJ, Voong KR, Levy LB, Choi S, Frank SJ, Lee AK, Mahmood U, McGuire SE, Schlembach PJ, Du W, Johnson J, Kudchadker RJ, Kuban DA. Patient-Reported Urinary, Bowel and Sexual Function After Hypofractionated Intensity-Modulated Radiation Therapy for Prostate Cancer: Results from a Randomized Trial. Am J Clin Oncol. e-Pub 2016. PMID: 27635624.
53. Bian SX, Kuban DA, Levy LB, Oh J, Choi S, McGuire SE, Frank SJ, Mahmood U, Nguyen PL, Pugh TJ, Lee AK, Hoffman KE . The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer. Am J Clin Oncol 39(4):368-73, 2016. e-Pub 2014. PMID: 24732810.
54. Sohn W, Resnick MJ, Greenfield S, Kaplan SH, Phillips S, Koyama T, Goodman M, Hamilton AS, Hashibe M, Hoffman KE, Paddock LE, Stroup AM, Wu XC, Penson DF, Barocas DA. Impact of Adherence to Quality Measures for Localized Prostate Cancer on Patient-Reported Health-Related Quality of Life Outcomes, Patient Satisfaction, and Treatment-Related Complications. Med Care 54(8):738-44, 2016. e-Pub 2016. PMID: 27219634.
55. Pugh TJ, Choi S, Nogueras-Gonzalaez GM, Nguyen QN, Mahmood U, Frank SJ, Mathai B, Zhu XR, Sahoo N, Gillin M, Kuban DA, Hoffman KE , McGuire SE, Lee AK. Proton Beam Therapy for Localized Prostate Cancer: Results from a Prospective Quality of Life Trial. International Journal of Particle Therapy 3(1):27-36. e-Pub 2016. PMID: 31772973.
56. Davis JW, Ward JF, Pettaway CA, Wang X, Kuban D, Frank SJ, Lee AK, Pisters LL, Matin SF, Shah JB, Karam JA, Chapin BF, Papadopoulos JN, Achim M, Hoffman KE , Pugh TJ, Choi S, Troncoso P, Logothetis CJ, Kim J. Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int 118(1):68-76, 2016. e-Pub 2015. PMID: 26059275.
57. Mahal BA, Muralidhar V, Chen YW, Choueiri TK, Hoffman KE, Hu JC, Sweeney CJ, Yu JB, Feng FY, Trinh QD, Nguyen PL. Gleason 5 + 3 = 8 Prostate Cancer: Much More like Gleason 9?. BJU Int 118(1):95-101, 2016. e-Pub 2015. PMID: 26207642.
58. Benedict SH, Hoffman K, Martel MK, Abernethy AP, Asher AL, Capala J, Chen RC, Chera B, Couch J, Deye J, Efstathiou JA, Ford E, Fraass BA, Gabriel PE, Huser V, Kavanagh BD, Khuntia D, Marks LB, Mayo C, McNutt T, Miller RS, Moore KL, Prior F, Roelofs E, Rosenstein BS, Sloan J, Theriault A, Vikram B. Overview of the American Society for Radiation Oncology-National Institutes of Health-American Association of Physicists in Medicine Workshop 2015: Exploring Opportunities for Radiation Oncology in the Era of Big Data. Int J Radiat Oncol Biol Phys 95(3):873-9, 2016. PMID: 27302503.
59. Ho V, Ku-Goto MH, Zhao H, Hoffman KE, Smith BD, Giordano SH. Regional differences in recommended cancer treatment for the elderly. BMC Health Serv Res 16:262, 2016. e-Pub 2016. PMID: 27417075.
60. Shirvani SM, Jiang J, Likhacheva A, Hoffman KE , Shaitelman SF, Caudle A, Buchholz TA, Giordano SH, Smith BD. Trends in local therapy utilization and cost for early-stage breast cancer in older women: Implications for payment and policy reform. Int J Radiat Oncol Biol Phys 95(2):605-16, 2016. e-Pub 2016. PMID: 27034179.
61. Dinh KT, Reznor G, Muralidhar V, Mahal BA, Nezolosky MD, Choueiri TK, Hoffman KE , Hu JC, Sweeney CJ, Trinh QD, Nguyen PL. Association of Androgen Deprivation Therapy With Depression in Localized Prostate Cancer. J Clin Oncol 34(16):1905-12, 2016. e-Pub 2016. PMID: 27069075.
62. Goodman KA, Patton CE, Fisher GA, Hoffe SE, Haddock MG, Parikh PJ, Kim J, Baxter NN, Czito BG, Hong TS, Herman JM, Crane CH, Hoffman KE. Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the RAND/UCLA Appropriateness Method. Pract Radiat Oncol 6(3):166-75, 2016. e-Pub 2015. PMID: 26922700.
63. Kalra S, Basourakos S, Abouassi A, Achim M, Volk RJ, Hoffman KE, Davis JW, Kim J. The implications of ageing and life expectancy in prostate cancer treatment. Nat Rev Urol 13(5):289-95, 2016. e-Pub 2016. PMID: 27001016.
64. Ovalle V, Strom EA, Godby J, Shaitelman SF, Stauder MC, Amos RA, Kuerer HM, Woodward WA, Hoffman KE . Proton Partial-Breast Irradiation for Early-Stage Cancer: Is It Really So Costly?. Int J Radiat Oncol Biol Phys 95(1):49-51, 2016. PMID: 27084625.
65. Mahal BA, Chen YW, Efstathiou JA, Muralidhar V, Hoffman KE, Yu JB, Feng FY, Beard CJ, Martin NE, Orio PF, Nguyen PL. National trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base study. Cancer 122(10):1505-12, 2016. e-Pub 2016. PMID: 26970022.
66. Williams SB, Huo J, Chamie K, Hu JC, Giordano SH, Hoffman KE , Dinney CPN, Kamat AM, Shih YT. Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer. Eur Urol Focus. e-Pub 2016. PMID: 28753760.
67. Muralidhar V, Catalano PJ, Reznor G, Mahal BA, Choueiri TK, Sweeney CJ, Martin NE, Beard CJ, Chen YW, Nezolosky MD, Hoffman KE, Feng FY, Trinh QD, Nguyen PL. Variation in National Use of Long-Term ADT by Disease Aggressiveness Among Men With Unfavorable-Risk Prostate Cancer. J Natl Compr Canc Netw 14(4):421-8, 2016. PMID: 27059190.
68. Kalra S, Basourakos S, Abouassi A, Achim M, Volk R, Hoffman K, Davis J, Kim J. The implications of aging and life expectancy in prostate cancer treatment. Nature Reviews Urology. e-Pub 2016.
69. Chen YW, Mahal BA, Muralidhar V, Nezolosky M, Beard CJ, Den RB, Feng FY, Hoffman KE, Martin NE, Orio PF, Nguyen PL. Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 94(4):683-90, 2016. e-Pub 2015. PMID: 26972640.
70. O'Neil B, Koyama T, Alvarez J, Conwill RM, Albertsen PC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE, Hoffman RM, Kaplan SH, Stanford JL, Stroup AM, Paddock LE, Wu XC, Stephenson RA, Resnick MJ, Barocas DA, Penson DF. The Comparative Harms of Open and Robotic Prostatectomy in Population-Based Samples. J Urol 195(2):321-9, 2016. e-Pub 2015. PMID: 26343985.
71. Muralidhar V, Xiang M, Orio PF, Martin NE, Beard CJ, Feng FY, Hoffman KE, Nguyen PL. Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer. J Contemp Brachytherapy 8(1):1-6, 2016. e-Pub 2016. PMID: 26985191.
72. Koontz BF, Benda R, De Los Santos J, Hoffman KE, Huq MS, Morrell R, Sims A, Stevens S, Yu JB, Chen RC. U.S. Radiation Oncology Practice Patterns for Post-Treatment Survivor Care. Pract Radiat Oncol 6(1):50-6, 2016. e-Pub 2015. PMID: 26603597.
73. Bishop AJ, Ensor J, Moulder SL, Shaitelman SF, Edson MA, Whitman GJ, Bishnoi S, Hoffman KE , Stauder MC, Valero V, Buchholz TA, Ueno NT, Babiera G, Woodward WA. Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy. Cancer 121(24):4324-32, 2015. e-Pub 2015. PMID: 26348887.
74. Muralidhar V, Chen MH, Reznor G, Moran BJ, Braccioforte MH, Beard CJ, Feng FY, Hoffman KE , Choueiri TK, Martin NE, Sweeney CJ, Trinh QD, Nguyen PL. Definition and Validation of "Favorable High-Risk Prostate Cancer": Implications for Personalizing Treatment of Radiation-Managed Patients. Int J Radiat Oncol Biol Phys 93(4):828-35, 2015. e-Pub 2015. PMID: 26530751.
75. Shaitelman SF, Schlembach PJ, Arzu I, Ballo M, Bloom ES, Buchholz D, Chronowski GM, Dvorak T, Grade E, Hoffman KE , Kelly P, Ludwig M, Perkins GH, Reed V, Shah S, Stauder MC, Strom EA, Tereffe W, Woodward WA, Ensor J, Baumann D, Thompson AM, Amaya D, Davis T, Guerra W, Hamblin L, Hortobagyi G, Hunt KK, Buchholz TA, Smith BD. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial. JAMA Oncol 1(7):931-41, 2015. e-Pub 2015. PMID: 26247543.
76. Chen RC, Hoffman KE , Sher DJ, Showalter TN, Morrell R, Chen AB, Benda R, Nguyen PL, Movsas B, Hardenbergh P. Development of a standard survivorship care plan template for radiation oncologists. Practical Radiation Oncology 6(1):57-65, 2015. e-Pub 2015. PMID: 26778795.
77. Ziehr DR, Chen MH, Zhang D, Braccioforte MH, Moran BJ, Mahal BA, Hyatt AS, Basaria SS, Beard CJ, Beckman JA, Choueiri TK, D'Amico AV, Hoffman KE , Hu JC, Martin NE, Sweeney CJ, Trinh QD, Nguyen PL. Association of Androgen Deprivation Therapy with Excess Cardiac-Specific Mortality in Men with Prostate Cancer. BJU Int 116(3):358-65, 2015. e-Pub 2014. PMID: 25124891.
78. Strom EA, Amos RA, Shaitelman SF, Kerr MD, Hoffman KE , Smith BD, Tereffe W, Stauder MC, Perkins GH, Amin MD, Wang X, Poenisch F, Ovalle V, Buchholz TA, Babiera G, Woodward WA. Proton partial breast irradiation in the supine position: treatment description and reproducibility of a multibeam technique. Pract Radiat Oncol 5(4):e283-90, 2015. e-Pub 2015. PMID: 25804105.
79. Muralidhar V, Dinh KT, Mahal BA, Ziehr DR, Chen YW, Viswanathan VB, Nezolosky MD, Choueiri TK, Hoffman KE , Hu JC, Sweeney CJ, Trinh QD, Nguyen PL. Differential post-prostatectomy cancer-specific survival of occult T3 vs. clinical T3 prostate cancer: Implications for managing patients upstaged on prostate magnetic resonance imaging. Urol Oncol 33(7):330.e19-25, 2015. e-Pub 2015. PMID: 25990612.
80. Holliday EB, Ahmed AA, Yoo SK, Jagsi R, Hoffman KE . Does Cancer Literature Reflect Multidisciplinary Practice? A Systematic Review of Oncology Studies in the Medical Literature Over a 20-Year Period. Int J Radiat Oncol Biol Phys 92(4):721-31, 2015. e-Pub 2015. PMID: 26104927.
81. Resnick MJ, Barocas DA, Morgans AK, Phillips SE, Koyama T, Albertsen PC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE , Hoffman RM, Kaplan SH, McCollum D, Paddock LE, Stanford JL, Stroup AM, Wu XC, Penson DF. The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research. Eur Urol 67(6):1019-25, 2015. e-Pub 2014. PMID: 25174325.
82. Mahal BA, Hoffman KE , Efstathiou JA, Nguyen PL. National Trends in the Recommendation of Radiotherapy After Prostatectomy for Prostate Cancer Before and After the Reporting of a Survival Benefit in March 2009. Clin Genitourin Cancer 13(3):e167-72, 2015. e-Pub 2014. PMID: 25554010.
83. Bishop AJ, Ensor J, Moulder SL, Shaitelman SF, Edson MA, Whitman GJ, Bishnoi S, Hoffman KE , Stauder MC, Valero V, Buchholz TA, Ueno NT, Babiera G, Woodward WA. Prognosis for Patients with Metastatic Breast Cancer Who Acheive "No Evidence-of-Disease" Status After Systematic or Local Therapy. Oncology (Williston Park)(29), 2015. PMID: 25930789.
84. Resnick MJ, Lacchetti C, Bergman J, Hauke RJ, Hoffman KE , Kungel TM, Morgans AK, Penson DF. Prostate Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement. J Clin Oncol 33(9):1078-85, 2015. e-Pub 2015. PMID: 25667275.
85. Jagsi R, Bekelman JE, Chen A, Chen RC, Hoffman K , Shih YC, Smith BD, Yu JB. In reply to Rusthoven and Kavanagh. Int J Radiat Oncol Biol Phys 91(3):680-1, 2015. e-Pub 2015. PMID: 25680609.
86. Mahal BA, Inverso G, Aizer AA, Ziehr DR, Hyatt AS, Choueiri TK, Hoffman KE , Hu JC, Beard CJ, D'Amico AV, Martin NE, Orio PF, Trinh QD, Nguyen PL. Incidence and Determinants of 1-Month Mortality after Cancer-Directed Surgery. Ann Oncol 26(2):399-406, 2015. e-Pub 2014. PMID: 25430935.
87. Thaker NG, Hoffman KE, Stauder MC, Shaitelman SF, Strom EA, Tereffe W, Smith BD, Perkins GH, Huo L, Munsell MF, Pusztai L, Buchholz TA, Woodward WA. The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer. Springerplus 4:36, 2015. e-Pub 2015. PMID: 25674496.
88. Holliday EB, Yang G, Jagsi R, Hoffman KE , Bennett KE, Grace C, Zietman AL. Fate of manuscripts rejected from the Red Journal. Int J Radiat Oncol Biol Phys 91(1):3-10, 2015. PMID: 25835616.
89. Mahmood U, Levy LB, Nguyen PL, Lee AK, Kuban DA, Hoffman KE . Current Clinical Presentation and Treatment of Localized Prostate Cancer in the United States. J Urol 192(6):1650-6, 2014. e-Pub 2014. PMID: 24931803.
90. Mahal BA , Hoffman KE , Efstathiou JA, Nguyen PL. National Trends in the Recommendation of Post-Prostatectomy Radiotherapy for Prostate Cancer Before and After the Reporting of a Survival Benefit in March 2009. Clinical Genitourinary Cancer, 2014. e-Pub 2014.
91. Mahal BA, Aizer AA, Ziehr DR, Hyatt AS, Choueiri TK, Hu JC, Hoffman KE, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Kim SP, Trinh QD, Nguyen PL. Racial Disparities in Prostate Cancer--Specific Mortality in Men With Low-Risk Prostate Cancer. Clin Genitourin Cancer 12(5):e189-95, 2014. e-Pub 2014. PMID: 24861952.
92. Walker GV, Grant SR, Guadagnolo BA, Hoffman KE, Smith BD, Koshy M, Allen PK, Mahmood U. Disparities in Stage at Diagnosis, Treatment, and Survival in Nonelderly Adult Patients With Cancer According to Insurance Status. J Clin Oncol 32(28):3118-25, 2014. e-Pub 2014. PMID: 25092774.
93. Jagsi R, Bekelman JE, Chen A, Chen RC, Hoffman K , Shih YC, Smith BD, Yu JB. Considerations for Observational Research using Large Datasets in Radiation Oncology. Int J Radiat Oncol Biol Phys 90(1):11-24, 2014. PMID: 25195986.
94. Hoffman KE , Niu J, Shen Y, Jiang J, Davis JW, Kim J, Kuban DA, Perkins GH, Shah JB, Smith GL, Volk RJ, Buchholz TA, Giordano SH, Smith BD. Physician variation in management of low-risk prostate cancer; a population-based cohort study. JAMA Intern Med 174(9):1450-9, 2014. e-Pub 2014. PMID: 25023650.
95. Hoffman KE , Pugh SL, James JL, Scarantino C, Movsas B, Valicenti RK, Fortin A, Pollock J, Kim H, Brachman DG, Berk LB, Bruner DW, Kachnic LA. The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial. Qual Life Res 23(6):1841-58, 2014. e-Pub 2014. PMID: 24492945.
96. Dayyani F, Hoffman K , Eifel P, Guo C, Vikram R, Pagliaro LC, Pettaway C. Management of Advanced Primary Urethral Carcinomas. BJU Int 114(1):25-31, 2014. e-Pub 2014. PMID: 24447439.
97. Aizer AA, Falit B, Mendu ML, Chen MH, Choueiri TK, Hoffman KE , Hu JC, Martin NE, Trinh QD, Alexander BM, Nguyen PL. Cancer-Specific Outcomes Among Young Adults Without Health Insurance. J Clin Oncol 32(19):2025-2030, 2014. e-Pub 2014. PMID: 24888800.
98. Madsen LT, Kuban DA, Choi S, Davis JW, Kim J, Lee AK, Domain D, Levy L, Pisters LL, Pettaway CA, Ward JF, Logothetis C, Hoffman KE . Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic. J Natl Compr Canc Netw 12(7):993-8, 2014. PMID: 24994920.
99. Aizer AA, Chen MH, Parekh A, Choueiri TK, Hoffman KE , Kim SP, Martin NE, Hu JC, Trinh QD, Nguyen PL. Refusal of Curative Radiation Therapy and Surgery Among Patients With Cancer. Int J Radiat Oncol Biol Phys. e-Pub 2014. PMID: 24803037.
100. Aizer AA, Wilhite TJ, Chen MH, Graham PL, Choueiri TK, Hoffman KE , Martin NE, Trinh QD, Hu JC, Nguyen PL. Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer 120(10):1532-9, 2014. e-Pub 2014. PMID: 24863392.
101. Resnick MJ, Barocas DA, Morgans AK, Phillips SE, Chen VW, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE , Kaplan SH, Paddock LE, Stroup AM, Wu XC, Koyama T, Penson DF. Contemporary Prevalence of Pre-Treatment Urinary, Sexual, Hormonal, and Bowel Dysfunction: Defining the Population At-Risk for Harms of Prostate Cancer Treatment. Cancer 120(8):1263-71, 2014. e-Pub 2014. PMID: 24510400.
102. Hoffman KE, Voong KR, Pugh TJ, Skinner H, Levy LB, Takiar V, Choi S, Du W, Frank SJ, Johnson J, Kanke J, Kudchadker RJ, Lee AK, Mahmood U, McGuire SE, Kuban DA. Risk of Late Toxicity in Men Receiving Dose-Escalated Hypofractionated Intensity Modulated Prostate Radiation Therapy: Results From a Randomized Trial. Int J Radiat Oncol Biol Phys 88(5):1074-84, 2014. PMID: 24661661.
103. Wang J, Kudchadker Rajat, Choi S, Pettaway CA, Choi H, Hobbs BD, Occena MC, McGuire SE, Pugh TJ, Hoffman KE ,Mahmood U, Kuban DA. Local recurrence map to guide target volume delineation after radical prostatectomy. Practical Radiation Oncology, 2014. e-Pub 2014.
104. Mahmood U, Pugh T, Frank S, Levy L, Walker G, Haque W, Koshy M, Graber W, Swanson D, Hoffman K , Kuban D, Lee A. Declining use of brachytherapy for the treatment of prostate cancer. Brachytherapy 13(2):157-62, 2014. e-Pub 2013. PMID: 24050892.
105. MacDermed DM, Houtman KM, Thang SH, Allen PK, Caudle AS, Gainer SM, Hunt KK, Perkins GH, Shaitelman SF, Smith BD, Strom EA, Tereffe W, Woodward WA, Buchholz TA, Hoffman KE . Therapeutic radiation dose delivered to the low axilla during whole breast radiation therapy in the prone position: Implications for targeting the undissected axilla. Pract Radiat Oncol 4(2):116-22, 2014. e-Pub 2013. PMID: 24890352.
106. Smith GL, Jiang J, Buchholz TA, Xu Y, Hoffman KE , Giordano SH, Hunt KK, Smith BD. Benefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: Impact of patient stratification on breast preservation. Int J Radiat Oncol Biol Phys 88(2):274-84, 2014. e-Pub 2013. PMID: 24268788.
107. Du W, Cho SH, Zhang X, Hoffman KE , Kudchadker RJ. Quantification of beam complexity in intensity-modulated radiation therapy treatment plans. Med Phys 41(2):021716, 2014. PMID: 24506607.
108. Caudle AS, Yi M, Hoffman KE , Mittendorf EA, Babiera GV, Hwang RF, Meric-Bernstam F, Sahin AA, Hunt KK. Impact of Identification of Internal Mammary Sentinel Lymph Node Metastasis in Breast Cancer Patients. Ann Surg Oncol 21(1):60-5, 2014. e-Pub 2013. PMID: 24046126.
109. Takiar V, Akay CL, Stauder MC, Tereffe W, Alvarez RH, Hoffman KE , Perkins GH, Strom EA, Buchholz TA, Ueno NT, Babiera G, Woodward WA. Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation. Springerplus 3:166, 2014. e-Pub 2014. PMID: 24711988.
110. Aizer AA, Chen MH, McCarthy EP, Mendu ML, Koo S, Wilhite TJ, Graham PL, Choueiri TK, Hoffman KE, Martin NE, Hu JC, Nguyen PL. Marital Status and Survival in Patients With Cancer. J Clin Oncol 31(31):3869-76, 2013. e-Pub 2013. PMID: 24062405.
111. Weksberg DC, Allen PK, Hoffman KE, Litton JK, Strom EA, Shah RR, Kuerer HM, Hunt KK, Buchholz TA, Mittendorf EA. Outcomes and Predictive Factors for Salvage Therapy After Local-Regional Recurrence Following Neoadjuvant Chemotherapy and Breast Conserving Therapy. Ann Surg Oncol 20(11):3430-7, 2013. e-Pub 2013. PMID: 23720073.
112. Pugh TJ, Munsell MF, Choi S, Nguyen QN, Mathai B, Zhu XR, Sahoo N, Gillin M, Johnson JL, Amos RA, Dong L, Mahmood U, Kuban DA, Frank SJ, Hoffman KE , McGuire SE, Lee AK. Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. e-Pub 2013. PMID: 24139077.
113. Parekh A, Chen MH, D'Amico AV, Dosoretz DE, Ross R, Salenius S, Graham PL, Beckman JA, Beard CJ, Choueiri TK, Ennis RD, Hoffman KE, Hu JC, Ma J, Martin NE, Nguyen PL. Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer. Brachytherapy 12(5):415-21, 2013. e-Pub 2013. PMID: 23651926.
114. Aizer A, Chen MH, McCarthy E, Mendu M, Koo S, Wilhite T, Graham P, Choueiri T, Hoffman KE, Martin N, Hu J, Nguyen P. Martial Status and Survival in Patients with Cancer. J Clin Oncol, 2013. PMID: 24062405.
115. Nguyen QN, Levy LB, Lee AK, Choi SS, Frank SJ, Pugh TJ, McGuire S, Hoffman K, Kuban DA. Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation. Cancer 119(18):3265-71, 2013. e-Pub 2013. PMID: 23798338.
116. Beard CJ, Travis LB, Chen MH, Arvold ND, Nguyen PL, Martin NE, Kuban DA, Ng AK, Hoffman KE. Outcomes in stage I testicular seminoma: A population-based study of 9193 patients. Cancer 119(15):2771-7, 2013. e-Pub 2013. PMID: 23633409.
117. Cerne JZ, McGuire SE, Grant SR, Munsell MF, Lee AK, Kudchadker RJ, Choi SL, Mahmood U, Hoffman KE, Pugh TJ, Frank SJ, Kuban DA. Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients. Prostate Cancer Prostatic Dis. e-Pub 2013. PMID: 23939133.
118. Barocas DA, Chen V, Cooperberg M, Goodman M, Graff J, Greenfield S, Hamilton A, Hoffman KE, Kaplan S, Koyama T, Morgans A, Phillips S, Resnick M, Stroup A, Wu XC, Penson DF. Using a population-based observational cohort study to address difficult comparative effectiveness research questions: The CEASAR study. Journal of Comparative Effectiveness Research 2(4):445-460, 2013. PMID: 24236685.
119. Hoffman KE, Kuban DA. Lymph node-positive prostate cancer: the benefit of local therapy. Oncology (Williston Park) 27(7):655, 660-1, 2013. PMID: 23977760.
120. Pugh TJ, Frank SJ, Achim M, Kuban DA, Lee AK, Hoffman KE, McGuire SE, Swanson DA, Kudchadker R, Davis JW. Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy. Brachytherapy 12(3):204-9, 2013. e-Pub 2012. PMID: 22673704.
121. Efstathiou JA, Nassif DS, McNutt TR, Bogardus CB, Bosch W, Carlin J, Chen RC, Chou H, Eggert D, Fraass BA, Goldwein J, Hoffman KE, Hotz K, Hunt M, Kessler M, Lawton CA, Mayo C, Michalski JM, Mutic S, Potters L, Rose CM, Sandler HM, Sharp G, Tomé W, Tran PT, Wall T, Zietman AL, Gabriel PE, Bekelman JE. Practice-Based Evidence to Evidence-Based Practice: Building the National Radiation Oncology Registry. J Oncol Pract 9(3):e90-e95, 2013. PMID: 23942508.
122. Wang X, Zhang X, Li X, Amos RA, Shaitelman SF, Hoffman K, Howell R, Salehpour M, Zhang SX, Sun TL, Smith B, Tereffe W, Perkins GH, Buchholz TA, Strom EA, Woodward WA. Accelerated Partial-Breast Irradiation Using Intensity-Modulated Proton Radiotherapy: Do Uncertainties Outweigh Potential Benefits?. Br J Radiol. e-Pub 2013. PMID: 23728947.
123. Bian SX, Kuban DA, Levy LB, Oh J, Castle KO, Pugh TJ, Choi S, McGuire SE, Nguyen QN, Frank SJ, Nguyen PL, Lee AK, Hoffman KE. Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer. Ann Oncol, Indian Excerpted Edition 4(2), 2013.
124. Hoffman KE, Niu J, Giordano SH, Ho V, Smith BD. Prostate Cancer Treatment Patterns in the State of Texas, 2004-2007. TPHA 65(2):36-42, 2013.
125. Castle KO, Hoffman KE, Levy LB, Lee AK, Choi S, Nguyen QN, Frank SJ, Pugh TJ, McGuire SE, Kuban DA. Is Androgen Deprivation Therapy Necessary in All Intermediate Risk Prostate Cancer Patients Treated in the Dose Escalation Era?. Int J Radiat Oncol Biol Phys 85(3):693-9, 2013. e-Pub 2012. PMID: 22836052.
126. Mittendorf EA, Buchholz TA, Tucker SL, Meric-Bernstam F, Kuerer HM, Gonzalez-Angulo AM, Bedrosian I, Babiera GV, Hoffman K, Yi M, Ross MI, Hortobagyi GN, Hunt KK. Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy. Ann Surg 257(2):173-9, 2013. PMID: 23291658.
127. McGuire SE, Lee AK, Cerne JZ, Munsell MF, Levy LB, Kudchadker RJ, Choi SL, Nguyen QN, Hoffman KE, Pugh TJ, Frank SJ, Corn PG, Logothetis CJ, Kuban DA. PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation Therapy Era. Int J Radiat Oncol Biol Phys 85(1):e39-46, 2013. e-Pub 2012. PMID: 23102837.
128. Parekh A, Chen MH, Hoffman KE, Choueiri TK, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, Graham PL, D'Amico AV, Nguyen PL. Reduced Penile Size and Treatment Regret in Men With Recurrent Prostate Cancer After Surgery, Radiotherapy Plus Androgen Deprivation, or Radiotherapy Alone. Urology 81(1):130-5, 2013. PMID: 23273077.
129. Arvold ND, Catalano PJ, Sweeney CJ, Hoffman KE, Nguyen PL, Balboni TA, Fosså SD, Travis LB, Beard CJ. Barriers to the Implementation of Surveillance for Stage I Testicular Seminoma. Int J Radiat Oncol Biol Phys 84(2):383-9, 2012. e-Pub 2012. PMID: 22349043.
130. Holmes JA, Wang AZ, Hoffman KE, Hendrix LH, Rosenman JG, Carpenter WR, Godley PA, Chen RC. Is Primary Prostate Cancer Treatment Influenced by Likelihood of Extraprostatic Disease? A Surveillance, Epidemiology and End Results Patterns of Care Study. Int J Radiat Oncol Biol Phys 84(1):88-94, 2012. e-Pub 2012. PMID: 22300560.
131. Bian SX, Kuban DA, Levy LB, Oh J, Castle KO, Pugh TJ, Choi S, McGuire SE, Nguyen QN, Frank SJ, Nguyen PL, Lee AK, Hoffman KE. Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer. Ann Oncol 23(9):2346-52, 2012. e-Pub 2012. PMID: 22357249.
132. Jhaveri PM, Sun Z, Ballas L, Followill DS, Hoffman KE, Jiang J, Smith BD. Emergence of Integrated Urology-Radiation Oncology Practices in the State of Texas. Int J Radiat Oncol Biol Phys 84(1):15-9, 2012. e-Pub 2012. PMID: 22789491.
133. Albert JM, Liu DD, Shen Y, Pan IW, Shih YC, Hoffman KE, Buchholz TA, Giordano SH, Smith BD. Nomogram to Predict the Benefit of Radiation for Older Patients With Breast Cancer Treated With Conservative Surgery. J Clin Oncol 30(23):2837-43, 2012. e-Pub 2012. PMID: 22734034.
134. Nguyen PL, Chen MH, Hoffman KE, Chen RC, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, D'Amico AV. Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer. BJU Int 110(2):201-205, 2012. e-Pub 2011. PMID: 22085233.
135. Pinnix C, Perkins GH, Strom EA, Tereffe W, Woodward W, Oh JL, Arriaga L, Munsell MF, Kelly P, Hoffman KE, Smith BD, Buchholz TA, Yu TK. Topical Hyaluronic Acid vs. Standard of Care for the Prevention of Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer: Single-Blind Randomized Phase III Clinical Trial. Int J Radiat Oncol Biol Phys 83(4):1089-94, 2012. e-Pub 2011. PMID: 22172912.
136. Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease?. Eur J Cancer 48(11):1664-71, 2012. e-Pub 2012. PMID: 22336663.
137. Caudle AS, Hunt KK, Mittendorf EA, Tucker SL, Hoffman KE, Gainer SM, Lucci A, Kuerer HM, Meric-Bernstam F, Babiera G, Sahin AA, Shah RR. American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on Surgeon Practice Patterns. Am Surg Oncol, 2012. e-Pub 2012.
138. Sharp HJ, Swanson DA, Pugh TJ, Zhang M, Phan J, Kudchadker R, Bruno TL, Kuban DA, Lee AK, Choi S, Nguyen QN, Hoffman KE, McGuire SE, Frank SJ. Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy. Pract Radiat Oncol 2(3):e7-e13, 2012. e-Pub 2012. PMID: 24674130.
139. Hoffman KE, Mittendorf EA, Buchholz TA. Optimising radiation treatment decisions for patients who receive neoadjuvant chemotherapy and mastectomy. Lancet Oncol 13(6):e270-6, 2012. PMID: 22652235.
140. Akay CL, Meric-Bernstam F, Hunt KK, Grubbs EG, Bedrosian I, Tucker SL, Kuerer HM, Hoffman KE, Babiera GV, Strom EA, Buchholz TA, Mittendorf EA. Evaluation of the MD Anderson prognostic index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy. Ann Surg Oncol 19(3):901-7, 2012. e-Pub 2011. PMID: 21861223.
141. Nguyen PL, Chen MH, Beckman JA, Beard CJ, Martin NE, Choueiri TK, Hu JC, Hoffman KE, Dosoretz DE, Moran BJ, Salenius SA, Braccioforte MH, Kantoff PW, D'Amico AV, Ennis RD. Influence of androgen deprivation therapy (ADT) on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure (CHF) or myocardial infarction (MI). Int J Radiat Oncol Biol Phys 82(4):1411-6, 2012. e-Pub 2011. PMID: 21708431.
142. Wang X, Pan T, Pinnix C, Zhang SX, Salehpour M, Sun TL, Gladish G, Strom EA, Perkins GH, Tereffe W, Woodward W, Hoffman KE, Buchholz TA, Yu TK. Cardiac motion during deep-inspiration breath-hold: implications for breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 82(2):708-14, 2012. e-Pub 2011. PMID: 21444161.
143. Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Improvement in prostate cancer survival over time: a 20-year analysis. Cancer J 18(1):1-8, 2012. PMID: 22290249.
144. Caudle AS, Yu TK, Tucker SL, Bedrosian I, Litton JK, Gonzalez-Angulo AM, Hoffman K, Meric-Bernstam F, Hunt KK, Buchholz TA, Mittendorf EA. Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy. Breast Cancer Res 14(3):R83, 2012. e-Pub 2012. PMID: 22621334.
145. Hoffman KE, Neville BA, Mamon HJ, Kachnic LA, Katz MS, Earle CC, Punglia RS. Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness. Cancer 118(1):248-57, 2012. e-Pub 2011. PMID: 21692071.
146. Nguyen PL, Je Y, Schutz FA, Hoffman KE, Hu JC, Parekh A, Beckman JA, Choueiri TK. Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. JAMA 306(21):2359-66, 2011. PMID: 22147380.
147. Shirvani SM, Pan IW, Buchholz TA, Shih YC, Hoffman KE, Giordano SH, Smith BD. Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women. Cancer 117(20):4595-605, 2011. e-Pub 2011. PMID: 21710653.
148. Caudle AS, Hunt KK, Kuerer HM, Meric-Bernstam F, Lucci A, Bedrosian I, Babiera GV, Hwang RF, Ross MI, Feig BW, Hoffman K, Litton JK, Sahin AA, Yang W, Hortobagyi GN, Buchholz TA, Mittendorf EA. Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial. Ann Surg Oncol 18(9):2407-12, 2011. e-Pub 2011. PMID: 21327455.
149. Wang X, Amos RA, Zhang X, Taddei PJ, Woodward WA, Hoffman KE, Yu TK, Tereffe W, Oh J, Perkins GH, Salehpour M, Zhang SX, Sun TL, Gillin M, Buchholz TA, Strom EA. External-beam accelerated partial breast irradiation using multiple proton beam configurations. Int J Radiat Oncol Biol Phys 80(5):1464-72, 2011. e-Pub 2010. PMID: 20708848.
150. Mak RH, McCarthy EP, Das P, Hong TS, Mamon HJ, Hoffman KE. Adoption of preoperative radiation therapy for rectal cancer from 2000 to 2006: a surveillance epidemiology and end results patterns of care study. Int J Radiat Oncol Biol Phys 80(4):978-84, 2011. e-Pub 2010. PMID: 20961695.
151. Albert JM, Buzdar AU, Guzman R, Allen PK, Strom EA, Perkins GH, Woodward WA, Hoffman KE, Tereffe W, Hunt KK, Buchholz TA, Oh JL. Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control. Breast Cancer Res Treat 128(2):421-7, 2011. e-Pub 2011. PMID: 21553292.
152. Nguyen PL, Chen MH, Choueiri TK, Hoffman KE, Hu JC, Martin NE, Beard CJ, Dosoretz DE, Moran BJ, Katin MJ, Braccioforte MH, Ross R, Salenius SA, Kantoff PW, D'Amico AV. Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size. Int J Radiat Oncol Biol Phys 79(5):1318-22, 2011. e-Pub 2010. PMID: 20605366.
153. Nguyen PL, Gu X, Lipsitz SR, Choueiri TK, Choi WW, Lei Y, Hoffman KE, Hu JC. Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol 29(12):1517-24, 2011. e-Pub 2011. PMID: 21402604.
154. Hoffman KE, Nguyen PL, Chen MH, Chen RC, Choueiri TK, Hu JC, Kuban DA, D'Amico AV. Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials. J Urol 185(1):116-20, 2011. e-Pub 2010. PMID: 21074194.
155. Nguyen PL, Chen RC, Hoffman KE, Trofimov A, Efstathiou JA, Coen JJ, Shipley WU, Zietman AL, Talcott JA. Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trial. Int J Radiat Oncol Biol Phys 78(4):1081-5, 2010. e-Pub 2010. PMID: 20207497.
156. Ahove DA, Hoffman KE, Hu JC, Choueiri TK, D'Amico AV, Nguyen PL. Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence? Implications for a risk-adapted follow-up strategy. Urology 76(5):1201-5, 2010. e-Pub 2010. PMID: 20709376.
157. Walker GV, Smith GL, Perkins GH, Oh JL, Woodward W, Yu TK, Hunt KK, Hoffman K, Strom EA, Buchholz TA. Population-based analysis of occult primary breast cancer with axillary lymph node metastasis. Cancer 116(17):4000-6, 2010. PMID: 20564117.
158. Hoffman KE, Chen MH, Moran BJ, Braccioforte MH, Dosoretz D, Salenius S, Katin MJ, Ross R, D'Amico AV. Prostate-cancer specific mortality and the extent of therapy in healthy elderly men with high-risk prostate cancer. Cancer 116(11):2590-5, 2010. e-Pub 2010. PMID: 20310055.
159. Hoffman KE, Nguyen PL, Ng AK, D'Amico AV. Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy. J Urol 183(5):1798-802, 2010. e-Pub 2010. PMID: 20299039.
160. Nguyen PL, Chen MH, Beard CJ, Suh WW, Choueiri TK, Efstathiou JA, Hoffman KE, Loffredo M, Kantoff PW, D'Amico AV. Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence. Cancer 116(3):610-5, 2010. e-Pub 2009. PMID: 19957321.
161. Hoffman KE, Yock TI. Radiation therapy for pediatric central nervous system tumors. J Child Neurol 24(11):1387-96, 2009. PMID: 19841427.
162. Hoffman KE, McCarthy EP, Recklitis CJ, Ng AK. Psychological distress in long-term survivors of adult-onset cancer: results from a national survey. Arch Intern Med 169(14):1274-81, 2009. PMID: 19636028.
163. Hong SH, Briggs J, Newman R, Hoffman K, Mendoza A, LeRoith D, Helman L, Yakar S, Khanna C. Murine osteosarcoma primary tumor growth and metastatic progression is maintained after marked suppression of serum insulin-like growth factor I. Int J Cancer 124(9):2042-9, 2009. PMID: 19132750.
164. Nguyen PL, Chen MH, Hoffman KE, Katz MS, D'Amico AV. Predicting the risk of pelvic node involvement among men with prostate cancer in the contemporary era. Int J Radiat Oncol Biol Phys 74(1):104-9. e-Pub 2009. PMID: 19286330.
165. Hoffman KE, Chen MH, Punglia RS, Beard CJ, D'Amico AV. Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant radiation treatment for stage I testicular seminoma. J Clin Oncol 26(24):3937-42, 2008. PMID: 18711182.
166. Hoffman KE, Hong TS, Zietman AL, Russell AH. External beam radiation treatment for rectal cancer is associated with a decrease in subsequent prostate cancer diagnosis. Cancer 112(4):943-9, 2008. PMID: 18098220.
167. Hoffman KE, Derdak J, Bernstein D, Reynolds JC, Avila NA, Gerber L, Steinberg SM, Chrousos G, Mackall CL, Mansky PJ. Metabolic syndrome traits in long-term survivors of pediatric sarcoma. Pediatr Blood Cancer 50(2):341-6, 2008. PMID: 17918262.
168. Hoffman KE, Horowitz NS, Russell AH. Healing of vulvo-vaginal radionecrosis following revascularization. Gynecol Oncol 106(1):262-4, 2007. PMID: 17507081.
169. Mansky P, Arai A, Stratton P, Bernstein D, Long L, Reynolds J, Chen D, Steinberg SM, Lavende N, Hoffman K, Nathan PC, Parks R, Augustine E, Chaudhry U, Derdak J, Wiener L, Gerber L, Mackall C. Treatment late effects in long-term survivors of pediatric sarcoma. Pediatr Blood Cancer 48(2):192-9, 2007. PMID: 16642490.
170. Gerber LH, Hoffman K, Chaudhry U, Augustine E, Parks R, Bernard M, Mackall C, Steinberg S, Mansky P. Functional outcomes and life satisfaction in long-term survivors of pediatric sarcomas. Arch Phys Med Rehabil 87(12):1611-7, 2006. PMID: 17141641.
171. Rowe-Taitt CA, Hazzard JW, Hoffman KE, Cras JJ, Golden JP, Ligler FS. Simultaneous detection of six biohazardous agents using a planar waveguide array biosensor. Biosens Bioelectron 15(11-12):579-89, 2000. PMID: 11213218.
172. Rowe-Taitt CA, Golden JP, Feldstein MJ, Cras JJ, Hoffman KE, Ligler FS. Array biosensor for detection of biohazards. Biosens Bioelectron 14(10-11):785-94, 2000. PMID: 10945453.
173. Bart JC, Judd LL, Hoffman KE, Wilkins AM, Kusterbeck AW. Application of a portable immunosensor to detect the explosives TNT and RDX in groundwater samples. Environmental Science Technology 31(5):1505-1511, 1997.

Invited Articles

1. Bian SX, Hoffman KE. Management of Prostate Cancer in Elderly Men. Semin Radiat Oncol 23(3):198-205, 2013. PMID: 23763886.
2. Pugh TJ, Nguyen BN, Kanke JE, Johnson JL, Hoffman KE. Radiation Therapy Modalities in Prostate Cancer. J Natl Compr Canc Netw 11(4):414-21, 2013. PMID: 23584344.
3. Hoffman KE, Kuban DA. Commentary on Lymph-node Positive Prostate Cancer: The Benefit of Local Therapy. Oncology 27(7), 2013.
4. Hoffman KE. Management of Older Men with Clinically Localized Prostate Cancer: The Significance of Advanced Age and Comorbidity. Semin Radiat Oncol 22(4):284-94, 2012. PMID: 22985811.
5. Nguyen PL, Hoffman KE. Adjuvant vs. Salvage Radiation for pT3 or Margin Positive Prostate Cancer. AUA News 16(10):18-20, 2011.
6. Hoffman KE, Nguyen PL. The Debate over Prostate Cancer Screening Guidelines. Virtual Mentor 13(1):10-15, 2011. e-Pub 2011. PMID: 23121809.
7. Hoffman KE, Buchholz TA. How Improved Local-Regional Therapy Impacts Survival. Current Breast Cancer Reports 2(2):83-89. e-Pub 2010.

Editorials

1. Hoffman KE, Whitman GJ. Commentary on: Screening Breast MR Imaging in Women with a History of Chest Irradiation. Breast Diseases: A Year Book Quarterly 23(2), 2012.
2. Hoffman KE. Estimating Recurrences Prevented From Using Trastuzumab in HER-2/neu-Positive Adjuvant Breast Cancer in the United States. Breast Diseases: A Year Book Quarterly 22(3):297, 2011.
3. Hoffman KE. Commentary on: Long-Term Survival Among Patients with Hodgkin's Lymphoma who Developed Breast Cancer. Breast Diseases: A Year Book Quarterly 22(4):364-365, 2011.
4. Hoffman KE. Commentary on: Transitioning to Breast Cancer Survivorship: Perspectives of Patients, Cancer Specialists, and Primary Care Providers. Breast Diseases: A Year Book Quarterly 21(2):125-126, 2010.
5. Hoffman KE, Harris JR. Commentary on: Prognostic value of triple-negative phenotype at the time of locally recurrent conservatively treated breast cancer. Breast Diseases: A Year Book Quarterly 20(2):172-174, 2009.

Abstracts

1. Ovalle V, Strom EA, Shaitelman SF, Hoffman KE, Amos R, Perkins GH, Tereffe W, Smith BD, Stauder MC, Woodward WA. Proton Partial Breast Irradiation: Detailed Description of Acute Clinico-Radiologic Effects. Cancers 2018, 2018.
2. Stauder MC,Shaitelman SF, Allen PK, Smith BD, Hoffman KE,Buchholz TA,Middleton LP, Chavez-Macgregor M, Caudle AS, Hunt KK, Meric-Bernstam F, Woodward WA. Postmastectomy Radiation Therapy After Positive Sentinel Lymph Node Biopsy and Completion Axillary Lymph Node Dissection. Int J Radiation Oncol Biol Phys 90(S1):S235-6, 2014.
3. Domain D, Hoffman KE, Madsen LT, Pettaway CA, Kim J, Davis JW, Lee AK, Pisters L, Levy L, Kuban DA. Clinical Trial Enrollment in a Multidisciplinary Prostate Cancer Clinic. I.J. Radiation Oncology, Biology, Physics 81(2):S565, 2011.
4. Hoffman KE, Kim J, Davis JW, Choi S, Pettaway C, Lee AK, Domain D, Levy L, Madsen LT, Kuban DA. Barriers to Active Surveillance as a Treatment Choice for Prostate Cancer. I.J. Radiation Oncology, Biology, Physics 81(2):S141-S142, 2011.
5. Hoffman KE, Madsen LT, Levy L, Pettaway C, Pisters L, Choi S, Kim J, Davis JW, Ward JF, Kuban DA. Prostate Cancer Treatment Selection after Counseling in a Multidisciplinary Prostate Cancer Clinic. I.J. Radiation, Oncology, Biology, Physics 81(2):S563-S564, 2011.
6. Hoffman KE, Neville BA, Mamon HJ, Kachnic LA, Katz MS, Earle CC, Punglia RS. Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness. Cancer 118(1):248-57, 2011. e-Pub 2011. PMID: 21692071.
7. Nguyen PL, Chen M, Chen RC, Hoffman KE, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, D’Amico AV. Comorbidity and Treatment Regret in Men with Recurrent Prostate Cancer, 2011.
8. Hoffman KE, Chen M, Nguyen PL, Bennett CL, Sartor AO, Stein K, Kuban DA, D'Amico AV. Factors Associated with a Delay in Diagnosis of Recurrent Prostate Cancer After Radical Prostatectomy, 2011.
9. Beard CJ, Chen M, Arvold ND, Nguyen PL, Ng AK, Hoffman KE. Long-Term Survival and Competing Causes of Death in Men with Stage I Seminoma. I.J. Radiation Oncology, Biology, Physics 78(3):S60, 2010.
10. Arvold ND, Catalano PJ, Sweeney CJ, Hoffman KE, Nguyen PL, Balboni TA, Fosså SD, Travis LB, Beard CJ. Patterns of care for stage I seminoma: a survey of American radiation oncologists. I.J. Radiation Oncology, Biology, Physics 78(3):S193, 2010.
11. Nguyen Q, Levy LB, Lee AK, Choi S, Frank SJ, Hoffman KE, McGuire S, Kuban DA. Risk Factors Predicting Failure And Prostate Cancer Mortality In High Risk Prostate Cancer Patients Treated With Definitive External Beam Radiation Therapy. I.J. Radiation Oncology, Biology, Physics 78(3):S125, 2010.
12. Hoffman KE, Symmans WF, Oh JL, Welela T, Yu TK, Perkins GH, Strom EA, Gonzalez-Angulo AM, Buchholz TA, Woodward WA. Pathologic features Predicting for High Rates of Local-Regional Recurrence after Neoadjuvant Chemotherapy and Radiation Therapy for Breast Cancer. I.J. Radiation Oncology, Biology, Physics 78(3):S97, 2010.
13. Kim MM, Hoffman KE, Levy LB, Master P, Frank SJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Improvement in Prostate Cancer Outcomes Over Time: A Twenty-Year Analysis. I.J. Radiation Oncology, Biology, Physics 78(3):S191, 2010.
14. McGuire SE, Levy LB, Settle SH, Choi S, Nguyen QN, Hoffman KE, Frank SJ, Lee AK, Kuban DA. PSA Response to Neoadjuvant Androgen Suppression Therapy Prior to High Dose Radiotherapy Predicts Survival in Clinically Localized High Risk Prostate Cancer. I.J. Radiation Oncology, Biology, Physics 78(3):S124, 2010.
15. Kuban DA, Nogueras-Gonzalez GM, Hamblin L, Lee AK, Choi S, Frank SJ, Nguyen QN, Hoffman KE, McGuire SE, Munsell MF. Preliminary Report of a Randomized Dose Escalation Trial for Prostate Cancer Using Hypofractionation. I.J. Radiation Oncology, Biology, Physics 78(3):S58, 2010.
16. Nguyen PL, Chen M, Dosoretz DE, Moran BJ, Salenius SA, Braccioforte MH, Beard CJ, Hoffman KE ,D’Amico AV, Ennis RD. The Adverse Impact of Androgen Deprivation Therapy on All-Cause Mortality in Men with High-Risk Prostate Cancer and a History of Congestive Heart Failure (CHF) or Myocardial Infarction (MI). I.J. Radiation Oncology, Biology, Physics 78(3):A350, 2010.
17. Hoffman KE. Medicare Claims Data: Rapid Answers to Big Questions, 2010.
18. Morikawa LK, Levy LB, Choi S, Nguyen QN, McGuire S, Hoffman K, Frank SJ, Lee A, Kuban DA. Relationship Between PSA Failure and Death From Prostate Cancer After Radical External Beam Radiation Therapy, 2010.
19. Morikawa LK, Rajat K, Kanke J, Choi S, Nguyen QN, McGuire S, Hoffman K, Frank SJ, Lee A, Kuban DA. Endorectal balloon in Post-Operative Prostate Cancer Patients: Who Benefits From It?, 2010.
20. Walker GV, Smith GL, Allen P, Perkins GH, Oh JL, Woodward WA, Yu TK, Hunt KK, Hoffman K, Strom EA, Buchholz TA. Population-Based Analysis of Occult Primary Breast Cancer with Axillary Nodal Metastasis. Oncology 24(4 Suppl 3):2, 2010.
21. Hoffman KE, Chen M, Nguyen PL, D'Amico AV. Post-prostatectomy Radiation Therapy in the United States: Patterns of Care. International Journal of Radiation Oncology, Biology, Physics 75(3, Supplement):S90, 2009.
22. Hoffman KE, Abi-Raad R, Ancukiewicz M, Yeh E, Ryan P, Schapira L, Younger J, Smith B, Kuter I, Taghian A. Impact of Interstitial Fluid Pressure, Tumor Oxygenation, and Chemotherapy Drug Sequencing on Response to Neoadjuvant Chemotherapy and on Long-Term Local Control in Women Treated for Locally Advanced Breast Cancer. I.J. Radiation Oncology, Biology, Physics 69(3):S61-S62, 2007.

Book Chapters

1. Patterson ML, Davis JW, Kim JE, Hoffman KE, Osai WE, Kuban DA. Genitourinary Cancer Survivorship Management. In: The MD Anderson Cancer Center Survivorship Textbook. Springer, 2014.
2. Kuban DA, Hoffman KE, Corn P, Pettaway C. Prostate Cancer. In: 60 Years of Survival Outcomes at the University of Texas, MD Anderson Cancer Center, 35-43, 2013.
3. Bart JC, Judd LL, Hoffman KE, Wilkins AM, Charles PT, Kusterbeck AQ. Detection and Quantitation of the Explosives 2, 4, 6-Trinitrotoluene and Hexahydro-1, 3, 5-triazine in Groundwater Using a Continuous Flow Immunosensor. In: Immunochemical Technology for Environmental Applications: Washington, DC, 210-220, 1997.